The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
出版年份 2019 全文链接
标题
The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
作者
关键词
-
出版物
Cancers
Volume 11, Issue 9, Pages 1220
出版商
MDPI AG
发表日期
2019-08-21
DOI
10.3390/cancers11091220
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
- (2019) Debarati Ghosh et al. Cancer Cell International
- Thr55 phosphorylation of p21 by MPK38/MELK ameliorates defects in glucose, lipid, and energy metabolism in diet-induced obese mice
- (2019) Hyun-A. Seong et al. Cell Death & Disease
- Function of p21 (Cip1/Waf1/CDKN1A) in Migration and Invasion of Cancer and Trophoblastic Cells
- (2019) Kreis et al. Cancers
- Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity
- (2018) Rayan S. Moussa et al. FREE RADICAL BIOLOGY AND MEDICINE
- Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer
- (2018) Mariangela Morlando et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma
- (2018) Yang Yu et al. Cell Death & Disease
- Senescence and senotherapeutics: a new field in cancer therapy
- (2018) Vassilios Myrianthopoulos et al. PHARMACOLOGY & THERAPEUTICS
- The Senescence–Stemness Alliance – A Cancer-Hijacked Regeneration Principle
- (2018) Maja Milanovic et al. TRENDS IN CELL BIOLOGY
- Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma
- (2018) Afak Rasheed Salman Zaidi et al. Journal of Cell Communication and Signaling
- Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2
- (2018) Arnatchai Maiuthed et al. Cancers
- Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness
- (2017) Tsai-Tsen Liao et al. Molecular Oncology
- Senescence-associated reprogramming promotes cancer stemness
- (2017) Maja Milanovic et al. NATURE
- p21: A Two-Faced Genome Guardian
- (2017) Alexandros G. Georgakilas et al. TRENDS IN MOLECULAR MEDICINE
- Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression
- (2017) Zhenyao Chen et al. Cell Death & Disease
- p16Ink4a and p21Cip1/Waf1 promote tumour growth by enhancing myeloid-derived suppressor cells chemotaxis
- (2017) Atsushi Okuma et al. Nature Communications
- DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression
- (2017) Alexis R. Barr et al. Nature Communications
- The Cell Cycle Inhibitors p21 Cip1 and p27 Kip1 Control Proliferation but Enhance DNA Damage Resistance of Glioma Stem Cells
- (2017) Olivia Morris-Hanon et al. NEOPLASIA
- p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy
- (2016) Wafik S. El-Deiry CANCER RESEARCH
- Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression
- (2016) Suzan Ruijtenberg et al. CELL CYCLE
- p21 shapes cancer evolution
- (2016) Vasily S. Romanov et al. NATURE CELL BIOLOGY
- Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing
- (2016) Panagiotis Galanos et al. NATURE CELL BIOLOGY
- Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
- (2016) Nina-Naomi Kreis et al. Oncotarget
- Increased levels of p21(CIP1/WAF1) correlate with decreased chondrogenic differentiation potential in synovial membrane progenitor cells.
- (2015) Anand Oliveira Masson et al. MECHANISMS OF AGEING AND DEVELOPMENT
- P21 Deficiency Delays Regeneration of Skeletal Muscular Tissue
- (2015) Nobuaki Chinzei et al. PLoS One
- Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy
- (2015) Frank Louwen et al. Oncotarget
- Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition
- (2015) Nina-Naomi Kreis et al. Oncotarget
- Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapy
- (2015) Hui Zhao et al. Oncotarget
- Biology of the cell cycle inhibitor p21CDKN1A: molecular mechanisms and relevance in chemical toxicology
- (2014) Ilaria Dutto et al. ARCHIVES OF TOXICOLOGY
- SOX9 accelerates ESC differentiation to three germ layer lineages by repressing SOX2 expression through P21 (WAF1/CIP1)
- (2014) K. Yamamizu et al. DEVELOPMENT
- Cooperative actions of p21WAF1 and p53 induce Slug protein degradation and suppress cell invasion
- (2014) J. Kim et al. EMBO REPORTS
- Less understood issues: p21Cip1 in mitosis and its therapeutic potential
- (2014) N-N Kreis et al. ONCOGENE
- Differential Expression of STAT1 and p21 Proteins Predicts Pancreatic Cancer Progression and Prognosis
- (2014) Yu Sun et al. PANCREAS
- Cytoplasmic Localization of p21 Protects Trophoblast Giant Cells from DNA Damage Induced Apoptosis
- (2014) Christelle de Renty et al. PLoS One
- A novel p21 attenuator which is structurally related to sorafenib
- (2013) Hiromi I. Wettersten et al. CANCER BIOLOGY & THERAPY
- Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer
- (2013) Ruiwu Liu et al. Future Medicinal Chemistry
- Lats2 phosphorylates p21/CDKN1A after UV irradiation and regulates apoptosis
- (2013) H. Suzuki et al. JOURNAL OF CELL SCIENCE
- The opposite prognostic significance of nuclear and cytoplasmic p21 expression in resectable gastric cancer patients
- (2013) Yefei Huang et al. JOURNAL OF GASTROENTEROLOGY
- Aberrant promoter hypermethylation of p21 (WAF1/CIP1) gene and its impact on expression and role of polymorphism in the risk of breast cancer
- (2013) Marjan Askari et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A p21-ZEB1 Complex Inhibits Epithelial-Mesenchymal Transition through the MicroRNA 183-96-182 Cluster
- (2013) X. L. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells
- (2013) N-N Kreis et al. ONCOGENE
- PUMA Cooperates with p21 to Regulate Mammary Epithelial Morphogenesis and Epithelial-To-Mesenchymal Transition
- (2013) Yanhong Zhang et al. PLoS One
- p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
- (2013) Liz J. Valente et al. Cell Reports
- Cell cycle regulation by the intrinsically disordered proteins p21 and p27
- (2012) Mi-Kyung Yoon et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, “fueling” tumor growth via paracrine interactions, without an increase in neo-angiogenesis
- (2012) Claudia Capparelli et al. CELL CYCLE
- The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
- (2012) L. A. Stivala et al. CURRENT CANCER DRUG TARGETS
- p21WAF1 and tumourigenesis
- (2012) Noel A. Warfel et al. CURRENT OPINION IN ONCOLOGY
- Cellular senescence and cancer chemotherapy resistance
- (2012) Ryan R. Gordon et al. DRUG RESISTANCE UPDATES
- Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance
- (2012) Andrew J. Vincent et al. FEBS LETTERS
- Identification of Small Molecule Proliferating Cell Nuclear Antigen (PCNA) Inhibitor That Disrupts Interactions with PIP-box Proteins and Inhibits DNA Replication
- (2012) Chandanamali Punchihewa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck
- (2012) Zhongqiu Wang et al. Molecular Cancer
- p21 promotes error-free replication-coupled DNA double-strand break repair
- (2012) Maurizio Mauro et al. NUCLEIC ACIDS RESEARCH
- p21CIP1 mediates reciprocal switching between proliferation and invasion during metastasis
- (2012) X Qian et al. ONCOGENE
- Quinacrine-Mediated Autophagy and Apoptosis in Colon Cancer Cells Is Through a p53- and p21-Dependent Mechanism
- (2012) Purusottam Mohapatra et al. ONCOLOGY RESEARCH
- p21 as a Transcriptional Co-Repressor of S-Phase and Mitotic Control Genes
- (2012) Nuria Ferrándiz et al. PLoS One
- Therapeutic targeting of cancer cell cycle using proteasome inhibitors
- (2012) Namrata Rastogi et al. Cell Division
- Knockdown of p21Cip1/Waf1 enhances proliferation, the expression of stemness markers, and osteogenic potential in human mesenchymal stem cells
- (2011) Tu-Lai Yew et al. AGING CELL
- Polo-Box Domain Inhibitor Poloxin Activates the Spindle Assembly Checkpoint and Inhibits Tumor Growth in Vivo
- (2011) Juping Yuan et al. AMERICAN JOURNAL OF PATHOLOGY
- Current progress of siRNA/shRNA therapeutics in clinical trials
- (2011) John C. Burnett et al. Biotechnology Journal
- Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
- (2011) Xi Xia et al. BMC CANCER
- Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy
- (2011) Hiromi Inoue et al. CANCER BIOLOGY & THERAPY
- Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21WAF1/CIP1
- (2011) Nina-Naomi Kreis et al. CELL CYCLE
- Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
- (2011) Hong Shen et al. CURRENT PHARMACEUTICAL DESIGN
- Four faces of cellular senescence
- (2011) Francis Rodier et al. JOURNAL OF CELL BIOLOGY
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors
- (2011) Natalia G. Starostina et al. TRENDS IN CELL BIOLOGY
- Association between p21 Ser31Arg polymorphism and cancer risk: a meta-analysis
- (2011) Hongxia Ma et al. Chinese Journal of Cancer
- p21 Waf1/Cip1 Polymorphisms and Risk of Esophageal Cancer
- (2010) Wenjun Yang et al. ANNALS OF SURGICAL ONCOLOGY
- Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasis
- (2010) Xiaoyun Cheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High throughput screening of a small molecule one-bead-one-compound combinatorial library to identify attenuators of p21 as chemotherapy sensitizers
- (2010) See-Hyoung Park et al. CANCER BIOLOGY & THERAPY
- GATA-1 directly regulates p21 gene expression during erythroid differentiation
- (2010) Michael Papetti et al. CELL CYCLE
- Examination of the expanding pathways for the regulation of p21 expression and activity
- (2010) Yong-Sam Jung et al. CELLULAR SIGNALLING
- CRL2LRR-1 Targets a CDK Inhibitor for Cell Cycle Control in C. elegans and Actin-Based Motility Regulation in Human Cells
- (2010) Natalia G. Starostina et al. DEVELOPMENTAL CELL
- Restoring p53 tumor suppressor activity as an anticancer therapeutic strategy
- (2010) Jesse D Martinez Future Oncology
- Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
- (2010) Roelof Koster et al. JOURNAL OF CLINICAL INVESTIGATION
- Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts
- (2010) HuanChen Cheng et al. MOLECULAR BIOLOGY REPORTS
- Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
- (2010) Ornella Cazzalini et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- p21WAF1/CIP1and cancer: A shifting paradigm?
- (2009) Andrei L. Gartel BIOFACTORS
- The role of p53 in limiting somatic cell reprogramming
- (2009) Yan Liu et al. CELL RESEARCH
- Extracellular Signal-Regulated Kinase 2-Dependent Phosphorylation Induces Cytoplasmic Localization and Degradation of p21Cip1
- (2009) C. Y. Hwang et al. MOLECULAR AND CELLULAR BIOLOGY
- Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
- (2009) Andrea Viale et al. NATURE
- Linking the p53 tumour suppressor pathway to somatic cell reprogramming
- (2009) Teruhisa Kawamura et al. NATURE
- Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
- (2009) Hyenjong Hong et al. NATURE
- p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
- (2009) Shu-Ping Wang et al. NATURE CELL BIOLOGY
- p21CIP1attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo
- (2009) Manran Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CDK Inhibitors: Cell Cycle Regulators and Beyond
- (2008) Arnaud Besson et al. DEVELOPMENTAL CELL
- p21 and p27: roles in carcinogenesis and drug resistance
- (2008) Abde M. Abukhdeir et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Cyclin-dependent Kinase Inhibitor, p21WAF1/CIP1, Is Involved in Adipocyte Differentiation and Hypertrophy, Linking to Obesity, and Insulin Resistance
- (2008) Noriyuki Inoue et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- p21 differentially regulates DNA replication and DNA-repair-associated processes after UV irradiation
- (2008) G. Soria et al. JOURNAL OF CELL SCIENCE
- Antisense Attenuation of p21 Sensitizes Kidney Cancer to Apoptosis in Response to Conventional DNA Damaging Chemotherapy Associated With Enhancement of Phospho-p53
- (2008) See-Hyoung Park et al. JOURNAL OF UROLOGY
- MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression
- (2008) I. Ivanovska et al. MOLECULAR AND CELLULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started